India Market Research Reports: GlobalData

Showing posts with label GlobalData. Show all posts

Wednesday, July 3, 2013

Industry Overview: Methanol Industry Outlook in India to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants

GlobalDatas report, Methanol Industry Outlook in India to 2016 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of India Methanol industry. The research presents major market trends affecting the Methanol industry in India. The report covers India Methanol plants and presents installed capacity by process and technology. In addition, it presents Methanol demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Methanol producers in India. Overall, the report presents a comprehensive coverage of India Methanol industry including all the major parameters.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/methanol-industry-outlook-in-india-to-2016-market-size-company-share-price-trends-capacity-forecasts-of-all-active-and-planned-plants

Scope

Methanol industry supply scenario in India from 2000 to 2016 consisting of plants capacity growth, installed plant capacity by production process and technology
Information of all active and planned Methanol plants in India with capacity forecasts to 2016
Detailed information on all operating and planned projects covering details such as process, technology, operator and equity details
Methanol industry market dynamics in India from 2000 to 2016 consisting of market size, demand and production outlook, demand by end use sector, and average prices
Trade balance data from 2000 to 2016 including import and export data, net exports and imports as percentage of demand in the country
Company snapshots including company overview, business description and information on the current and upcoming Methanol plants
Company shares of key Methanol producers in the country

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/154265

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Market Report: India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

GlobalDatas new report, India In Vitro Diagnostics Market Outlook to 2018 Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the India In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/india-in-vitro-diagnostics-market-outlook-to-2018-clinical-chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-microbiology-culture

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
2011 company shares and distribution shares data for each of the seven market categories.
Global corporate-level profiles of key companies operating within the India In Vitro Diagnosticsmarket.
Key players covered include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Span Diagnostics Ltd. and others.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/155532

Website: http://www.marketresearchreports.biz/

New Report: PharmaPoint - Seasonal Influenza Vaccines India Drug Forecast and Market Analysis : MarketResearchReports.Biz

GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent intramuscular vaccines such as Sanofis Fluzone and Vaxigrip, GlaxoSmithKlines Fluarix and FluLaval and Novartis Fluvirin garner the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZenecas intranasal FluMist and Sanofis Fluzone IntraDermal, GlobalData projects a dramatic shift favoring the adoption of such vaccines over the traditional intramuscular vaccines. GlobalData also anticipates that manufacturers that launch quadrivalent formulations will steal market share, patient share, and revenue from the trivalent influenza vaccines currently available.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/pharmapoint-seasonal-influenza-vaccines-india-drug-forecast-and-market-analysis

The Indian influenza vaccine market is valued at $71 million for 2012. The market is forecast to grow slightly during the forecast period due to numerous market barriers overpowering any drivers of growth. Lack of a centralized healthcare policy regarding vaccination and limited awareness of the burden and threat of influenza among both Indian physicians and patients are examples of things hindering the growth of the influenza vaccine market in India.

Scope

Overview of seasonal influenza, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in India from 2012 to 2022.
Analysis of the impact of key events as well the drivers and restraints affecting the India seasonal influenza market.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/157686

Website: http://www.marketresearchreports.biz/

Tuesday, July 2, 2013

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis Event-Driven Update : MarketResearchReports.Biz

GlobalData has released its new Country report, PharmaPoint: Rheumatoid Arthritis India Drug Forecast and Market Analysis Event-Driven Update. The RA market is currently very dynamic, with the November 6, 2012 FDA approval of Pfizers Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lillys anti-BAFF, tabalumab and JAK1,2 inhibitor, baricitinib, and Rigel/AZs SYK inhibitor, fostamatinib. These compounds will challenge the current biologics in the attempt to dislodge the stronghold of the TNF inhibitors, if their safety and efficacy profiles are proven once they enter the market.

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/pharmapoint-rheumatoid-arthritis-india-drug-forecast-and-market-analysis-event-driven-update

Indian physicians included in our study typically follow guidelines such as ACR or EULAR, but also follow their own clinical experience. In India, the process to diagnosis a patient with RA usually begins with the PCP or GP regardless of which potential stage the patient is in, then progresses with the referral to a rheumatologist for further diagnosis and treatment as this occurs about 32% of the time. Also, most people seeking treatment are within the 35-55-year-old group. Within this age group, females and males are equally distributed according to our physician experts.

Scope

Overview of RA, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in India from 2011 to 2022.
Analysis of the impact of key events as well the drivers and restraints affecting the India rheumatoid arthritis market.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/158931

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for rheumatoid arthritis
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of rheumatoid arthritis drug performance in India
Obtain sales forecast from 2011-2022 in India

Blog: http://mrrfocuseconomics.blogspot.com/